Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20762)	5/14/1998 12:24:00 PM
From: Phil Cressman	Read Replies (3) \| Respond to of 32384

Nice LGND play by buying SRGN at current 50 cents, Almost a guaranteed money maker. Ligand is to payout shares based on $14 to give each SRGN shareholder 49cents per share on closing of first part of deal. If LGND is up $3 by then the value to each SRGN share is 60cents. Then when SRGN compound receives approval a further payment in cash or shares will be paid of about 23 cents. If this is paid in LGND shares(based on average over 10days trading at time of NDA) you can bet those shares will be worth more than 23 cents as LGND will bounce on this news. Worth passing on, although funds are tied up for a few months a very good return looks to be made.